Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. (Q37868371)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2011

Language	Label	Description	Also known as
English	Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.	scientific article published on May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

Nikolaos Kakouros

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Irene Savelieva

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Antonios Kourliouros

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A John Camm

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

610-625

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Current concepts in the pathogenesis of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Irbesartan in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Losartan and prevention of atrial fibrillation recurrence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers on patients following ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Upstream therapies after pulmonary vein ablation: five negative studies--what's next?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Inflammation as a risk factor for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Lack of effect of statins on maintenance of normal sinus rhythm following electrical cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Statin use and recurrence of atrial fibrillation after successful cardioversion.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of C-reactive protein reduction on paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Dose dependent effect of statins on postoperative atrial fibrillation after cardiac surgery among patients treated with beta blockers.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Impact of lipid-lowering therapy on outcomes in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Identifiers

10.1093/EUROPACE/EUR023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37868371&oldid=2138299524"